Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - News - U.S. Pharmaceutical Industry - February 15, 2019

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/15/19 - 7 Top Gainers In Healthcare Sector (IVC, OTLK, MDGL...)
Invacare is a manufacturer of medical equipment used in non-acute care settings. Although the net sales decreased 2.3% to $244.6 million in the fourth quarter of 2018, it was above the consensus analysts' estimate of $240.53 million. Outlook Therapeutics is a clinical-stage biopharmaceutical company developing a drug for the treatment of wet age-re
2/15/19 - AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) has coverage initiated with a Outperform rating
Analyst Ratings For AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Today, Credit Suisse Group initiated coverage on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a Outperform. There are 7 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is Buy with a
2/15/19 - Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has submitted a continuation patent application with U.S. Patent and Trademark Office to broaden the claims relating to the use of AD04 for opioid dependence and abuse, commonly referred to as Opio
2/15/19 - Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With New Animal Drug Applications and Veterinary Master Files
Agency: " Food and Drug Administration, HHS." Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the no
2/15/19 - Agios Pharmaceuticals Inc (NASDAQ:AGIO) gets upgraded to Outperform by Leerink Swann
Analyst Ratings For Agios Pharmaceuticals Inc (NASDAQ:AGIO) Today, Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock received an upgrade by Leerink Swann from Market Perform to Outperform. There are 9 Buy Ratings, 2 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Agios Pharmaceuticals Inc (NASDAQ:AGIO)
2/15/19 - ALKERMES PLC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
The following should be read in conjunction with our consolidated financial statements and related notes beginning on page F 1 of this Annual Report. We earn revenue on net sales of VIVITROL, ARISTADA and ARISTADA INITIO, which are proprietary products that we manufacture, market and sell in the U.S., and manufacturing and/or royalty revenues on
2/15/19 - Astellas and Affinivaxs novel pneumococcal vaccine enters human testing [T-break Tech (Middle East)]
About two years ago, Astellas licensed a novel pneumococcal vaccine technology from Affinivax with eyes on Pfizers Prevnar 13. The first patient has been dosed with the investigational vaccine, dubbed ASP3772, in a phase 1/ 2 study that aims to evaluate the vaccines safety, tolerability and immunogenicity, Affinivax said on Wednesday. We believe th
2/15/19 - Avapritinib receives Phase III clinical trial approval for GIST in China
CStone Pharmaceuticals today announced that the National Medical Products Administration recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven gastrointestinal stromal tumors. According to data from the NAVIGATOR Phase I clinical trial reported as of October
2/15/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad s Droplet Digital PCR technology, and the QXDx BCR-ABL% IS Kit are the industry s first digital PCR products to receive U.S. Food and Drug Administration clearance. Used t
2/15/19 - Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome
Bioblast Pharma Ltd., a clinical-stage, orphan disease-focused biotechnology company, and Team Sanfilippo, a nonprofit medical research foundation founded by parents of children with Sanfilippo Syndrome today announced a clinical collaboration to evaluate the safety and efficacy of Bioblast s proprietary Trehalose solution for the treatment of
2/15/19 - BioCorRx Inc. to Webcast Live at February 20th
BioCorRx Inc., based in Anaheim, CA, Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier, CEO/President and Lourdes Felix, CFO/COO, will present live at on February 20 th. DATE: Wednesday, February 20 th TIME: 1:00PM EST LINK:
2/15/19 - Blood Products Advisory Committee; Notice of Meeting
DATES: The meeting will be held on March 20, 2019, from 8:30 a.m. to 4:45 p.m., and March 21, 2019, from 8:30 a.m. to 5 p.m.. ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room, Silver Spring, MD 20993-0002. Answers to commonly asked questions including information regarding special accommodations
2/15/19 - Cerecor Announces CERC-301 Granted U.S. Patent
Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in pediatrics and neurology, announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,202,363 on Feb. 12, 2019, which is directed to CERC 301, an oral, NR2B-specific, NMDA re
2/15/19 - Clinical Trial Supplies Market 2019: In-Depth Market Research Report Movianto (An Owens & Minor Company), Thermo Fischer Scientific, Catalent Pharma Solutions, Almac Group, Patheon, Clinigen Group
The Clinical Trial Supplies studies spreads fantastic statistics that makes the document a handy asset for managers, industry professionals and different key individuals alongside charts and tables to help recognize Clinical Trial Supplies market patterns, drivers and challenges. The development rate is based on the instructional exam of the facts
2/15/19 - Contract Research Organization (CRO) Market Business Growth and Opportunities 2019 to 2025
Harrisburg, NC 02/15/2019 Global Contract Research Organization Market Size, Status And Forecast 2025. This report studies the Global Contract Research Organization market size, industry status and forecast, competition landscape and growth opportunity. Food Service Market Segment by Region: North America, United States, Canada, Mexico, Asia-
2/15/19 - COVENTRY, R.I. - Rhodes Pharmaceuticals is a sinister drugma
COVENTRY, R.I.- Rhodes Pharmaceuticals is a sinister drugmaker that most Rhode Islanders have never heard of, contends Domenic Esposito. In September, The Financial Times first reported the link between Rhodes Pharmaceuticals and Purdue Pharma, manufacturer of the controversial painkiller OxyContin. In 2007, four months after executives of Purdue p
2/15/19 - CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
CymaBay Therapeutics, Inc., today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for seladelpar for the treatment of early stage primary biliary cholangitis in combination with ursodeoxycholic acid in adult patients with an inadequate response to UDCA, or as monotherapy in adults unable to tolera
2/15/19 - Decipher Biosciences Announces Research Collaboration with Dendreon to Identify Genomic Drivers of Patient Response to Sipuleucel-T
Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, to apply genomic tumor profiling using the Decipher assay and GRID software to identify prostate cancer
2/15/19 - Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer's Disease
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today announced initiation of dosing in a Phase 1 b clinical study of DNL747 in patients with Alzheimer s disease, in collaboration with its partner Sanofi.. We are excited to advance DNL747 in a secon
2/15/19 - Establishment of TRICARE Select and Other TRICARE Reforms
Document Number: "Docket ID: DOD -2017- HA-0039". Agency: " Office of the Secretary, Department of Defense." The law makes significant changes to the TRICARE program, especially to the health maintenance organization- like health plan, known as TRICARE Prime; to the preferred provider organization health plan, previously known as TRICARE Extra and
2/15/19 - FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA (pembrolizumab) in Combination with Inlyta (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted and granted priority review for a new supplemental Biologics License Application for KEYTRUDA, Merck s anti-PD-1 therapy, in combination with Inlyta, a tyrosine kinase inhibitor, for the first-line treatment of patien
2/15/19 - Federal Register Table of Contents
Table of Contents Office of the Federal Register Agricultural Marketing Service RULES Establish Procedures to Meet Via Electronic Communications: Olives Grown in California, 4307-4309 PROPOSED RULES Marketing Order: Spearmint Oil Produced in the Far West; Salable Quantities and Allotment Percentages for the 2019-2020 Marketing Year, 4381-4387...
2/15/19 - Germany Clinical Trial Supply Market Size Worth $206 Million by 2025 | Hexa Research
Growing number of clinical trial studies in Germany is expected to keep the market buoyant over the coming years. Rising need for supply chain planning, software for inventory management, and ancillary supply chain management is also likely to contribute towards the growth of the Germany clinical trial supplies market. Germany clinical trial suppli
2/15/19 - Global Nanopharmaceuticals Market to Surpass US$ 168.91 Billion by 2026
According to Coherent Market Insights, the global nanopharmaceuticals market was valued at US$ 28,434.3 million in 2017, and is projected to exhibit a CAGR of 22.1% over the forecast period. For example, in August 2017, Jazz Pharmaceuticals received FDA approval for Vyxeos, used for the treatment of acute myeloid leukemia. For instance, in March 20
2/15/19 - Hemispherx Biopharma Announces Commencement of Rights Offering Subscription Period
Hemispherx Biopharma, Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, today announced that the subscription period for the rights offering has commenced. American Stock Transfer& Trust Company, LLC Attn: Reorg Department 6201 15th Avenue Brooklyn, NY 11219. Each right entitles the ho
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement